Human PD-ECGF quantitates human PD-ECGF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human PD-ECGF.
Accession number
2900072D10Rik ; ECGF ; ECGF1 ; facteur de croissance des cellules endothéliales 1 (dérivé des plaquettes) ; gliostatine ; hPD-ECGF ; MEDPS1 ; MNGIE ; MTDPS1 ; OTTHUMP00000196767 ; OTTHUMP00000196770 ; PD TP ; PDECGF ; PD-ECGF ; Pdgfec ; facteur de croissance dérivé des plaquettes, cellule endothéliale ; facteur de croissance des cellules endothéliales dérivé des plaquettes ; TdRPase ; thymidine phosphorylase ; TP ; TYMP
Dose range
0.4 to 100 pg/ml
Sensitivity of the dosage
0.4 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human PD-ECGF quantitates human PD-ECGF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human PD-ECGF.
Human PD-ECGF quantitates human PD-ECGF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human PD-ECGF.
An endothelial cell growth factor derived from platelets (PD-ECGF), identical to thymidine phosphorylase (TP) or gliostatin. In the presence of inorganic d-orthophosphate, it catalyzes the reversible phospholytic cleavage of thymidine and deoxyuridine at their respective bases and 2-deoxyribose-1-phosphate. It is both chemotactic and mitogenic to endothelial cells. It is also an angiogenic factor of non-heparin binding present in platelets. It is also involved in the transformation of fluoropyrimidines, which are cytotoxic agents used in the treatment of a range of malignancies into active cytotoxic metabolites.
Sensitivity
Sensitivity of the dosage: 0.4 ng/ml.
Measurement range
Dose range: 0.4 to 100 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Thymidine phosphorylase.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; Serum, 50 µl; Plasma, 50 µl).